Search

Author/Creator Erba, Harry P.

11. Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia. Issue 2 (4th December 2017)

Authors:
Walter, Roland B.; Michaelis, Laura C.; Othus, Megan; Uy, Geoffrey L.; Radich, Jerald P.; Little, Richard F.; Hita, Sandi; Saini, Lalit; Foran, James M.; Gerds, Aaron T.; Klepin, Heidi D.; Hay, Annette E.; Assouline, Sarit; Lancet, Jeffrey E.; Couban, Stephen; Litzow, Mark R.; Stone, Richard M.; ...
Journal:
American journal of hematology
Issue:
Volume 93:Issue 2(2018:Feb.)
Page Start:
E49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. (2nd March 2015)

Authors:
Swords, Ronan T.; Erba, Harry P.; DeAngelo, Daniel J.; Bixby, Dale L.; Altman, Jessica K.; Maris, Michael; Hua, Zhaowei; Blakemore, Stephen J.; Faessel, Hélène; Sedarati, Farhad; Dezube, Bruce J.; Giles, Francis J.; Medeiros, Bruno C.
Journal:
British journal of haematology
Issue:
Volume 169:Number 4(2015:May)
Page Start:
534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS. (4th July 2014)

Authors:
Zeidan, Amer M.; Lee, Ju‐Whei; Prebet, Thomas; Greenberg, Peter; Sun, Zhuoxin; Juckett, Mark; Smith, Mitchell R.; Paietta, Elisabeth; Gabrilove, Janice; Erba, Harry P.; Katterling, Rhett P.; Tallman, Martin S.; Gore, Steven D.; the Eastern Cooperative Oncology Group (ECOG) and North American Leuk...
Journal:
British journal of haematology
Issue:
Volume 167:Number 1(2014:Oct.)
Page Start:
62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203. Issue 7 (7th June 2021)

Authors:
Moseley, Anna; Othus, Megan; Garcia-Manero, Guillermo; Appelbaum, Frederick R.; Erba, Harry P.; Walter, Roland B.
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 7(2021)
Page Start:
1774
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials. Issue 13 (21st February 2017)

Authors:
Qu, Xiaoyu; Othus, Megan; Davison, Jerry; Wu, Yu; Yan, Liying; Meshinchi, Soheil; Ostronoff, Fabiana; Estey, Elihu H.; Radich, Jerry P.; Erba, Harry P.; Appelbaum, Frederick R.; Fang, Min
Journal:
Cancer
Issue:
Volume 123:Issue 13(2017)
Page Start:
2472
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Real‐world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower‐risk myelodysplastic syndromes. (21st November 2020)

Authors:
Patel, Jay L.; Abedi, Mehrdad; Cogle, Christopher R.; Erba, Harry P.; Foucar, Kathryn; Garcia‐Manero, Guillermo; Grinblatt, David L.; Komrokji, Rami S.; Kurtin, Sandra E.; Maciejewski, Jaroslaw P.; Pollyea, Daniel A.; Revicki, Dennis A.; Roboz, Gail J.; Savona, Michael R.; Scott, Bart L.; Sekeres...
Journal:
International journal of laboratory hematology
Issue:
Volume 43:Number 3(2021)
Page Start:
426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗